Senseonics

The Eversense, Eversense E3, and Eversense 365 Continuous Glucose Monitoring (CGM) Systems are protected by one or more U.S. patents.

The U.S. Food and Drug Administration announced a potential cybersecurity threat called SweynTooth on March 3, 2020; security researchers at Singapore University of Technology and Design publicly disclosed the vulnerabilities in mid-February.

Senseonics Deutschland GmbH is entering the German market directly for the first time to bring its implantable long-term CGM system to more patients. The page directs job seekers to Senseonics’ LinkedIn page for career opportunities.

Senseonics

Senseonics integrates its Eversense 365 implantable continuous glucose monitor with the **iLet insulin pump**, expanding compatibility beyond its existing partner. The move aims to enhance diabetes management by pairing real-time glucose tracking with automated insulin delivery. The system is expected to reach users before year-end.

Sep 2026DiabetechNews article

Senseonics Holdings generates **$11.7 million in Q1 2026 revenue**, marking an **87% year-over-year increase**. The company’s financial report highlights continued expansion in its core business operations. Senseonics specializes in wearable health technology, including continuous glucose monitoring (CGM) systems for diabetes management.

May 2026Investing News Network (INN)News article

Senseonics Holdings relocates its common stock listing from NYSE American to Nasdaq Global Select Market. The medical technology firm specializes in implantable continuous glucose monitoring (CGM) systems for diabetes management. The transfer aims to align with the company’s growth strategy and enhance shareholder value.

Nov 2025nasdaq.comNews article

Senseonics is now handling commercialization and distribution of the Eversense 365, a long-term implantable continuous glucose monitor (CGM), following a transition agreement with Ascensia. The move covers existing products and future iterations under the Eversense brand. Both companies signed a memorandum of understanding to formalize the shift.

Sep 2025Drug Delivery BusinessNews article